Previously, it was reported that ErbB2 and IGF1R can heterotrimerize with ErbB3 to enhance receptor activation and downstream signaling responses in ErbB2-overexpressing breast cancer cells [43]. The gene discussed is ERBB3; the disease is breast cancer.